This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • A National, Multicenter, Open Label, Randomized Ph...
Clinical trial

A National, Multicenter, Open Label, Randomized Phase III study for Induction therapy with BORTEZOMIB/ LENALIDOMIDE/ DEXAMETHASONE (VRD-GEM) followed by High-dose Chemotherapy with MELPHALAN-200 (MEL-200) vs. BUSULFAN/MELPHALAN (BUMEL) and Consolidation t

Read time: 1 mins
Last updated:9th Jul 2013
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest